Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Analogue of adrenocorticotropic hormone (ACTH)

Chemical Name


Foreign Names

  • Tetracosactidum (Latin)
  • Tetracosactid (German)
  • Tétracosactide (French)
  • Tetracosactida (Spanish)

Generic Names

  • Cosyntropin (OS: USAN)
  • Tetracosactide (OS: BAN, DCIT)
  • Tétracosactide (OS: DCF)
  • Ciba 30920 Ba (IS)
  • Corticotropin tetracosapeptide (IS)
  • Tetracosactrin (IS)
  • Tetracosactid (PH: Ph. Eur. 8)
  • Tetracosactide (PH: BP 2016, Ph. Eur. 8)
  • Tétracosactide (PH: Ph. Eur. 8)
  • Tetracosactidum (PH: Ph. Eur. 8)
  • Tetracosactide Acetate (OS: BANM, JAN)
  • Tetracosactidi hexaacetas (IS)
  • Tetracosactrin Acetate (IS)
  • Cosyntropin zinc hydroxide (IS)
  • Tetracosactrin Zinc Injection (PH: BP 2013)

Brand Names

  • Cortrosyn
    Amphastar, Canada; Amphastar, United States
  • Cosyntropin Sandoz
    Sandoz, United States
  • Synachten
    Novartis, Lebanon
  • Synachten Retard
    Novartis, Lebanon
  • Synacthen
    Novartis, Colombia; Novartis, Turkey; Sanolabor, Slovenia
  • Synacthen Depot
    Novartis, Egypt; Sigma-Tau Industrie Farmaceutiche Riunite, Austria
  • Synacthen-depot
    Novartis, Turkey
  • Synacthene
    IFET, Greece
  • Synacthène
    Sigma-Tau, France
  • Synacthene Depot
    IFET, Greece
  • Synacthene Retard
    IFET, Greece
  • Synacthène Retard (Tetracosactide and Zinc Chloride)
    Sigma-Tau, France
  • Cortrosyn
    Daiichi Sankyo, Japan
  • Cortrosyn Z
    Daiichi Sankyo, Japan
  • Nuvacthen
    Defiante Farmaceutica S.A., Spain
  • Nuvacthen Depot
    Defiante Farmaceutica S.A., Spain
  • Synachten Depot
    Novartis, Romania
  • Synacthen
    Biofutura Pharma, Italy; CD Pharma, Denmark; Defiante, Netherlands; Mallinckrodt, Switzerland; MPCA, Belgium; Novartis, Argentina; Novartis, New Zealand; Novartis Pharmaceuticals, Australia; Questcor Operations, United Kingdom; Sigma-tau, Germany; Sigma-Tau Industrie Farmaceutiche Riunite, Austria; Swedish Orphan Biovitrum Ltd., Ireland
  • Synacthen Depot
    Defiante, Portugal; Mallinckrodt, Switzerland; Novartis, New Zealand; Novartis, Oman; Novartis AH, South Africa; Nycomed, Israel; Questcor Operations, United Kingdom; Sigma-tau, Germany; MPCA, Belgium; Novartis, Chile; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.